Novo Nordisk · 2 days ago
Internship - National Commercial Sales Execution
Novo Nordisk is a global pharmaceutical company focused on creating lasting change for long-term health. The internship offers hands-on experience in national commercial execution, analytics, and cross-functional leadership, while enabling the intern to support real-world business priorities within the Deployment, Innovation, and National Execution team.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Supporting field execution across Sales Areas
Assisting with NovoCare Pharmacy
Managing and routing questions or issues received from the field to the appropriate partners
Partnering with Market Access and the National Director of Virtual Sales to support the addition and removal of Telehealth HCPs
Supporting trending and analysis of key execution KPIs to identify patterns, risks, and opportunities for Sales Areas
Preparing clear summaries and visuals to support leadership discussions
Collaborating with IT to help design and build a dynamic, scalable national dashboard accessible to all areas
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate degree in Business Administration, Marketing, Finance or a related discipline preferred
Class year of a Junior or Senior preferred
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase